VIP and dendritic cells: regulatory T cells in a human cell model
Evidence level: Cell study
Research question
Does VIP influence immune responses through dendritic cells? These cells present antigens and help direct the T-cell response.
Research model
The researchers differentiated human dendritic cells in the presence of VIP. They then examined the interaction with CD4 and CD8 T cells.
What was found?
VIP-conditioned dendritic cells displayed tolerogenic properties and were able to induce regulatory T-cell responses. The researchers also described reduced reactivity of certain CD8 T cells.
Limitations and interpretation
A tolerogenic property in a controlled cell culture does not prove efficacy in autoimmune diseases or transplantation. The study examines a specific cellular interaction and not a general safety profile.
Original publication
Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells. PMID: 16397128. View the original publication on PubMed.
This summary is based on the available source description and abstract; it is not a complete systematic review.
All Peptidera products are intended solely for scientific research and laboratory use. Not for human or animal consumption, self-administration, diagnosis, or treatment.
Related research products
View product specifications and available batch documentation. The studies discussed were not conducted with Peptidera products and do not prove the efficacy of our products. For laboratory research only; not for human or animal consumption.